HERMAN JOAN E
SEC Form 4 insider trading activity
HERMAN JOAN E has filed 8 SEC Form 4 filings (11 transaction rows) across 2 companies, including EHC, IONS, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Oct 19, 2026.
On the most recent filing, HERMAN JOAN E is listed as Director at IONIS PHARMACEUTICALS INC. Inside the rolling window, HERMAN JOAN E reported no open-market purchases and 1 open-market sale totaling $3.2M in IONS.
Companies traded
Other insiders at EHC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.2M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has HERMAN JOAN E made?
HERMAN JOAN E has filed 8 SEC Form 4 filings (11 transaction rows) across 2 companies, including EHC, IONS since 2025.
Which companies does HERMAN JOAN E trade?
HERMAN JOAN E has filed SEC Form 4 disclosures for 2 companies, including EHC, IONS.
When was HERMAN JOAN E's most recent SEC Form 4 filing?
HERMAN JOAN E's most recent SEC Form 4 filing on Tracefour is dated Oct 19, 2026.
What is HERMAN JOAN E's total buy and sell value in the current window?
Inside the rolling retention window, HERMAN JOAN E bought $0 and sold $3.2M based on SEC Form 4 filings.
What was HERMAN JOAN E's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 44,000 IONS shares on 2025-11-19, worth $3.2M, per SEC Form 4 filings.